To prevent autotoxicity, the vesicular monoamine transporter 2 (VMAT2) actively sequesters free cytoplasmic monoamines into vesicles (Lohr et al., 2014)
This compound is not approved as a drug, diagnostic, or dietary ingredient, and is not manufactured, packaged, or marketed for consumption, self experimentation, clinical application, or any use outside properly designed and ethically approved research protocols.
On the one hand, you could be experiencing diarrhea
The development is this: Why is it important
Based on current studies, researchers are encouraged to consider the following points when administering DSIP intranasally: The optimal dosing schedule will depend upon the studys methodology and desired outcome
Topical Treatments Several over-the-counter options may help minimize hair loss: Minoxidil (Rogaine): FDA-approved for treating hair loss, available in 2% and 5% formulations